Therapeutic nanoemulsions in ophthalmic drug administration: Concept in formulations and characterization techniques for ocular drug delivery
- PMID: 33069743
- DOI: 10.1016/j.jconrel.2020.10.025
Therapeutic nanoemulsions in ophthalmic drug administration: Concept in formulations and characterization techniques for ocular drug delivery
Abstract
The eye is the specialized part of the body and is comprised of numerous physiological ocular barriers that limit the drug absorption at the action site. Regardless of various efforts, efficient topical ophthalmic drug delivery remains unsolved, and thus, it is extremely necessary to advance the contemporary treatments of ocular disorders affecting the anterior and posterior cavities. Nowadays, the advent of nanotechnology-based multicomponent nanoemulsions for ophthalmic drug delivery has gained popularity due to the enhancement of ocular penetrability, improve bioavailability, increase solubility, and stability of lipophilic drugs. Nanoemulsions offer the sustained/controlled drug release and increase residence time which depend on viscosity, compositions, and stabilization process, etc.; hence, decrease the instillation frequency and improve patient compliance. Further, due to the nanosized of nanoemulsions, the sterilization process is easy as conventional solutions and cause no blur vision. The review aims to summarizes the various ocular barriers, manufacturing techniques, possible mechanisms to the retention and deep penetration into the eye, and appropriate excipients with their under-lying selection principles to prevent destabilization of nanoemulsions. This review also discusses the characterization parameters of ocular drug delivery to spike the interest of those contemplating a foray in this field. Here, in short, nanoemulsions are abridged with concepts to design clinically advantageous ocular drug delivery.
Keywords: Lipophilic drugs; Nanoemulsions; Ocular barriers; Ophthalmic drug delivery; Sustained release.
Copyright © 2020 Elsevier B.V. All rights reserved.
Similar articles
-
Recent advances in ocular drug delivery.Drug Dev Ind Pharm. 2013 Nov;39(11):1599-617. doi: 10.3109/03639045.2012.736515. Epub 2012 Nov 16. Drug Dev Ind Pharm. 2013. PMID: 23153114 Review.
-
Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.Pharm Nanotechnol. 2024;12(3):229-250. doi: 10.2174/2211738511666230816090046. Pharm Nanotechnol. 2024. PMID: 37587812 Review.
-
Recent updates on drug delivery approaches for improved ocular delivery with an insight into nanostructured drug delivery carriers for anterior and posterior segment disorders.Drug Deliv Transl Res. 2025 Jun;15(6):1828-1876. doi: 10.1007/s13346-024-01756-x. Epub 2024 Dec 14. Drug Deliv Transl Res. 2025. PMID: 39674854 Review.
-
Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration.Int J Pharm. 2021 Oct 25;608:121105. doi: 10.1016/j.ijpharm.2021.121105. Epub 2021 Sep 17. Int J Pharm. 2021. PMID: 34537269 Review.
-
Ocular preparations: the formulation approach.Drug Dev Ind Pharm. 2002 May;28(5):473-93. doi: 10.1081/ddc-120003445. Drug Dev Ind Pharm. 2002. PMID: 12098838 Review.
Cited by
-
Recent advances in the treatment and delivery system of diabetic retinopathy.Front Endocrinol (Lausanne). 2024 Feb 15;15:1347864. doi: 10.3389/fendo.2024.1347864. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38425757 Free PMC article. Review.
-
The Effect of High-Pressure Homogenization Conditions on the Physicochemical Properties and Stability of Designed Fluconazole-Loaded Ocular Nanoemulsions.Pharmaceutics. 2023 Dec 20;16(1):11. doi: 10.3390/pharmaceutics16010011. Pharmaceutics. 2023. PMID: 38276489 Free PMC article.
-
Lipid Nanoparticles as a Promising Drug Delivery Carrier for Topical Ocular Therapy-An Overview on Recent Advances.Pharmaceutics. 2022 Feb 27;14(3):533. doi: 10.3390/pharmaceutics14030533. Pharmaceutics. 2022. PMID: 35335909 Free PMC article. Review.
-
Overview of Recent Advances in Nano-Based Ocular Drug Delivery.Int J Mol Sci. 2023 Oct 19;24(20):15352. doi: 10.3390/ijms242015352. Int J Mol Sci. 2023. PMID: 37895032 Free PMC article. Review.
-
Preparation and Characterization Studies of Dorzolamide-Loaded Ophthalmic Implants for Treating Glaucoma.Turk J Pharm Sci. 2023 Jul 7;20(3):149-156. doi: 10.4274/tjps.galenos.2022.95752. Turk J Pharm Sci. 2023. PMID: 37417193 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical